东阿阿胶(000423) - 2024 Q3 - 季度财报

Financial Performance - The company's revenue for Q3 2024 reached ¥1,581,271,320.36, representing a 25.38% increase year-over-year[6] - Net profit attributable to shareholders was ¥413,567,484.71, a significant increase of 63.75% compared to the same period last year[6] - The net profit after deducting non-recurring gains and losses was ¥367,356,380.51, up 74.53% year-over-year[6] - Basic earnings per share for the quarter were ¥0.6437, reflecting a 64.13% increase from the previous year[6] - Operating profit increased by 39.84% to ¥1,342,559,579.23 compared to the previous period, driven by sales revenue growth and improved gross margin[10] - Net profit rose by 46.74% to ¥1,152,145,315.53, attributed to increased sales revenue and enhanced gross margin[10] - Total profit increased by 41.20% to ¥1,348,692,004.91, influenced by sales revenue growth and improved gross margin[10] - Total operating revenue for the third quarter reached ¥4,329,229,198.62, an increase of 26.3% compared to ¥3,428,282,500.66 in the same period last year[18] - Net profit attributable to shareholders of the parent company was ¥1,151,986,622.87, up 47.0% from ¥783,673,380.90 in the previous year[19] - Operating profit for the period was ¥1,342,559,579.23, representing a 39.9% increase from ¥960,039,278.58 in the prior year[18] - The company reported a total profit of ¥1,348,692,004.91, an increase of 41.2% from ¥955,142,627.93 in the previous year[19] Assets and Liabilities - Total assets at the end of the reporting period were ¥12,715,273,642.98, a decrease of 4.44% from the end of the previous year[6] - The company's equity attributable to shareholders decreased by 7.53% to ¥9,911,873,728.09 compared to the previous year[6] - Total assets decreased from CNY 13,306,306,533.41 at the beginning of the period to CNY 12,715,273,642.98 at the end of the period, representing a decline of approximately 4.44%[15] - Current assets decreased from CNY 10,536,889,490.97 to CNY 9,912,427,903.38, a reduction of about 5.91%[15] - Total liabilities increased from CNY 2,565,744,617.42 to CNY 2,781,693,939.85, an increase of approximately 8.43%[16] - Current liabilities increased from CNY 2,406,763,444.39 to CNY 2,635,564,233.00, an increase of about 9.52%[16] - The company's equity decreased from CNY 9,208,565,999.56 to CNY 8,477,565,068.86, a decline of approximately 7.95%[16] Cash Flow - Cash inflow from investment activities totaled ¥5,274,336,106.81, a 58.17% increase year-on-year, primarily due to the recovery of funds from financial products[10] - Cash outflow for investment activities reached ¥6,266,979,059.74, a 99.18% increase compared to the previous period, mainly due to increased financial product purchases[10] - Cash flow from operating activities was ¥4,130,691,699.34, compared to ¥3,564,807,491.53 in the same period last year, indicating a growth of 15.8%[20] - Operating cash inflow totaled CNY 4,247,132,197.06, an increase of 15.2% compared to CNY 3,687,681,692.33 in the previous year[21] - Net cash outflow from investment activities was CNY -992,642,952.93, a decrease from CNY 188,077,996.21 in the same period last year[21] - Cash received from investment activities was CNY 5,274,336,106.81, up from CNY 3,334,503,474.51 in the previous year[21] - Cash paid for investment activities was CNY 6,266,979,059.74, compared to CNY 3,146,425,478.30 in the same period last year[21] - Total cash outflow from financing activities reached CNY 1,967,729,659.15, compared to CNY 761,964,461.19 in the previous year[22] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 54,998, with the largest shareholder holding 23.50% of the shares[11] - The top ten shareholders collectively held 32.50% of the company's total share capital[12] Research and Development - Research and development expenses increased to ¥89,467,158.11, slightly up from ¥85,626,885.58 in the previous year[18] Product Development and Market Strategy - The company is expanding its product line with new offerings such as the "Peach Blossom Princess Ejiao Cake" and "Ejiao Instant Powder" targeting health-conscious consumers[4] - The company plans to enhance its market presence by focusing on male health supplements and leveraging proprietary technology for product development[4] - The company plans to continue expanding its market presence and investing in new product development to drive future growth[19] Expenses and Impairments - Management expenses rose by 31.45% to ¥275,885,485.14, mainly due to personnel growth and adjustments in social security and compensation[10] - Asset impairment losses increased by 226.88% to ¥33,159,225.80, influenced by the reversal of some asset impairment losses from inventory disposal[10] - The company reported a significant increase in cash paid to employees, totaling CNY 564,826,412.71, compared to CNY 472,591,156.35 in the previous year[21]